Science Market Update

$17.8 Million Awarded to the University of Minnesota to Support Materials Research Center

Posted by Laura Braden on Fri, Apr 03, 2015

University of MinnesotaWith a recent award from the National Science Foundation, the College of Science and Engineering at the University of Minnesota will receive a total of $17.8 million over the next 6 years to support the university's Materials Research Science and Engineering Center (MRSEC). 

Read More

Tags: Midwest, University of Minnesota, 2015, BioResearch Product Faire Event, MN, UMinn, Twin Cities, Materials Research

UW Madison Receives $8.3 Million to Establish Urology Research Center

Posted by Laura Braden on Fri, Mar 27, 2015

University of Wisconsin, MadisonThe prostate can cause problems for many men as they age, and some of these problems do not yet have solid treatments that can help with the problems. With the help of a recent $8.3 million grant from the National Institutes of Health (NIH) in late 2014, the University of Wisconsin, Madison will be able to establish a new Urology Research Center that will focus on studying the prostate and some common diseases associated with it. 

Read More

Tags: Midwest, WI, University of Wisconsin Madison, UWisc, 2015, BioResearch Product Faire Event, Madison, New research center, Urology

Minnesota Mayo Clinic Constructing $72M Hospital Expansion

Posted by Laura Braden on Wed, Mar 04, 2015

The Mayo Clinic in Rochester, MNThe Mayo Clinic is one of the most well-known research and treatment centers in the world. With facilities in Arizona, Minnesota, and Florida, the Mayo Clinic receives millions of dollars in funding each year, performs cutting edge research and clinical trials, and sees more than one million patients each year. 

Read More

Tags: Midwest, Rochester, Mayo Clinic, 2015, BioResearch Product Faire Event, MN, new construction, RMN

$25 Million in New Funding Donated to Washington University Genome Institute

Posted by Laura Braden on Wed, Feb 18, 2015

A recent $25 million donation will help the Washington University Genome Institute continue cancer and illness research.As one of only three large-scale, NIH funded genome centers in the United States, the Genome Institute at Washington University School of Medicine in St. Louis has been a large contributer to cancer research and the research of child illnesses since it was founded in 1993.

Read More

Tags: Washington University St. Louis, Midwest, WashU, 2015, BioResearch Product Faire Event, genomics research, MO, St Louis, new funding

New UMN Microbiology Research Facility (MRF) Under Construction With Expected 2015 Completion

Posted by Laura Braden on Tue, Feb 17, 2015

As one of the leading research institutions in the Midwest, it is no surprise that the University of Minnesota, Twin Cities is expanding its research space. Construction crews have been hard at work on the newest research building on-campus, the Microbiology Research Facility, which is expected to be completed by the end of 2015, with an open and operating in January, 2016. 

Read More

Tags: Midwest, new research building, University of Minnesota Twin Cities, 2015, MN, UMinn, Twin Cities, Microbiology Research Facility

New $81M Washington University Building on Track for 2015 Opening

Posted by Laura Braden on Tue, Feb 03, 2015

The new inter-disciplinary medical research building in St. Louis is expected to be completed in June 2015. In June 2015, the Medical School at Washington University in St. Louis will substantially grow thanks to a new medical building that is currently under construction. The new $81 million building, which began construction in 2013, will be composed of 138,000 square-feet of lab space in six-stories for researchers in different life science disciplines. (Image courtesy of Wikimedia Commons)

Read More

Tags: Midwest, Washington University, WashU, new research building, 2015, BioResearch Product Faire Event, MO, St Louis, new Building

UC Team Reduces Antibodies to Aid Transplants

Posted by Sam Asher on Thu, Jan 01, 2015

At the University of Cincinnati, researchers have developed a way to reduce the number of antibodies in a patient’s body. This may seem counterproductive without a complete understanding of what antibodies are good (and bad) for. Just ask E. Steve Woodle, MD, a researcher at UC who is also the director of the division of transplantation at the UC College of Medicine. He’ll tell you that antibodies view transplanted organs as threats and attack the organs instead of accepting them.

Read More

Tags: Midwest, Ohio, University of Cincinnati, 2015, Cincinnati, UCinci

Personalizing Cancer Treatment at Ann Arbor

Posted by Sam Asher on Thu, Dec 25, 2014

Personalization is all the rage in both the holiday shopping scene and in the realm of cancer treatment. The truth is, everyone wants to feel special, like his or her needs and desires are being specifically catered to. Bringing a new level of personalization to the cancer scene is the University of Michigan, Ann Arbor, where researchers are developing a way to grow a patient’s cancer outside of their body so that they can better monitor and test it.

Read More

Tags: Midwest, Michigan, University of Michigan Ann Arbor, 2015, UMich

Preventing Treatment-Induced Symptoms at WUSTL

Posted by Sam Asher on Thu, Dec 18, 2014

Sometimes treatment for some symptoms actually gives rise to other symptoms. These symptoms are called iatrogenic symptoms and reflect quite poorly on the physicians and clinics involved. As such, a focus in clinical biotechnology is to reduce iatrogenic symptoms. A study conducted by Washington University in St. Louis attempted to pinpoint the causes of iatrogenic symptoms after cancer treatment.

Read More

Tags: Washington University St. Louis, Midwest, WashU, 2015

$26 Million in Lab Funding For WUSTL Alzheimer's Clinical Trial

Posted by Laura Braden on Fri, Nov 14, 2014

Researchers at Washington University in St. Louis have received an immense amount of additional funding from the National Institute on Aging to assist them on the first large-scale clinical trial to study Alzheimer's disease that is underway. This clinical trial, called the Dominantly Inherited Alzheimer’s Network Trials Unit (DIAN-TU) will work with people who have dominantly inherited forms of Alzheimer's to identify new drugs that can slow the onset of the disease, or stop it altogether. 

Beginning with $5.5 million in funding this year, the trial will continue to receive funding from the NIH over the next five years to total $26 million. The National Institute of Aging has been supporting this research since 2012, when the project began. This new funding will allow the trial to add an additional 300-400 participants to the study, as well as assist the research team in adding new drugs to the study. The trial is being run in locations in the United States, Canada, Europe, and Australia, and this funding will help add 10-15 more locations. 

Read More

Tags: Midwest, Washington University, WashU, 2015, BioResearch Product Faire Event, MO, Washington Univsersity St. Louis

Subscribe to Company News